Laddar...
Treatment strategies for advanced hepatocellular carcinoma: Sorafenib vs hepatic arterial infusion chemotherapy
Sorafenib is used worldwide as a first-line standard systemic agent for advanced hepatocellular carcinoma (HCC) on the basis of the results of two large-scale Phase III trials. Conversely, hepatic arterial infusion chemotherapy (HAIC) is one of the most recommended treatments in Japan. Although ther...
Sparad:
| I publikationen: | World J Hepatol |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Baishideng Publishing Group Inc
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6177565/ https://ncbi.nlm.nih.gov/pubmed/30310535 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v10.i9.571 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|